Shares of Eli Lilly LLY have surged 16% in the past week, driven primarily by positive investor expectations around the ...

Eli Lilly's stock jumped over 5% on Tuesday after U.S.President Donald Trump unveiled a plan to lower U.S. drug prices, which ...

After nearly two years of sideways price action, Eli Lilly stock could soar to new highs between now and 2030.

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 5.5% in the afternoon session after reports revealed a ...

Over the past 10 years, the stock has attracted buying interest at this level 5 times and subsequently achieved an average ...

Analysts have set 12-month price targets for Eli Lilly, revealing an average target of $934.09, a high estimate of $1135.00, ...

Eli Lilly shares are trading higher Wednesday after Trump recently announced a deal with Pfizer as well as the 'TrumpRx' site to decrease prices.

Eli Lilly (NYSE: LLY) is now known for its weight loss drugs. Its stock has risen 150% since mid-2022 because of high demand ...

If you have been keeping an eye on Eli Lilly’s stock, you are not alone, and you are probably wondering if now is the right ...

Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs.

Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.

Lilly's orforglipron achieved less weight loss than some Wall Street analysts expected. The relatively high patient discontinuation rate in the phase 3 study of the drug also raised eyebrows.